questionsmedicales.fr
Tumeurs
Tumeurs par siège
Tumeurs du thorax
Tumeurs du thorax : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Tumeurs thoraciques
Biopsie
Imagerie médicale
Tomodensitométrie
IRM
Bronchoscopie
Marqueurs tumoraux
Tumeurs thoraciques
Suivi médical
Histologie
Tumeurs thoraciques
Diagnostic
Tests génétiques
Tumeurs thoraciques
Traitement ciblé
Symptômes
5
Symptômes
Tumeurs thoraciques
Essoufflement
Perte de poids
Tumeurs thoraciques
Symptômes
Hémoptysie
Tumeurs thoraciques
Symptômes
Fatigue
Tumeurs thoraciques
Symptômes
Types de tumeurs
Tumeurs thoraciques
Symptômes
Prévention
5
Prévention
Tabagisme
Agents cancérigènes
Dépistage
Tumeurs thoraciques
Prévention
Alimentation
Prévention
Tumeurs thoraciques
Exercice physique
Prévention
Tumeurs thoraciques
Vaccination
Prévention
Cancers
Traitements
5
Chirurgie
Chimiothérapie
Radiothérapie
Chirurgie
Tumeurs thoraciques
Stade de la maladie
Chimiothérapie
Tumeurs thoraciques
Traitement néoadjuvant
Radiothérapie
Tumeurs thoraciques
Traitement complémentaire
Thérapies ciblées
Tumeurs thoraciques
Traitement
Complications
5
Complications
Métastase
Insuffisance respiratoire
Douleur thoracique
Tumeurs thoraciques
Complications
Difficultés respiratoires
Tumeurs thoraciques
Complications
Thrombose
Tumeurs thoraciques
Complications
Complications post-chirurgicales
Tumeurs thoraciques
Chirurgie
Facteurs de risque
5
Facteurs de risque
Tabagisme
Amiante
Âge
Facteurs de risque
Tumeurs thoraciques
Antécédents médicaux
Facteurs de risque
Tumeurs thoraciques
Exposition professionnelle
Facteurs de risque
Tumeurs thoraciques
Mode de vie
Facteurs de risque
Tumeurs thoraciques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Tumeurs du thorax : Questions médicales les plus fréquentes",
"headline": "Tumeurs du thorax : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Tumeurs du thorax : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-21",
"dateModified": "2025-03-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Tumeurs du thorax"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Tumeurs par siège",
"url": "https://questionsmedicales.fr/mesh/D009371",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs par siège",
"code": {
"@type": "MedicalCode",
"code": "D009371",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.588"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Adénocarcinome pulmonaire",
"alternateName": "Adenocarcinoma of Lung",
"url": "https://questionsmedicales.fr/mesh/D000077192",
"about": {
"@type": "MedicalCondition",
"name": "Adénocarcinome pulmonaire",
"code": {
"@type": "MedicalCode",
"code": "D000077192",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.588.894.797.520.055"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Adénocarcinome bronchioloalvéolaire",
"alternateName": "Adenocarcinoma, Bronchiolo-Alveolar",
"url": "https://questionsmedicales.fr/mesh/D002282",
"about": {
"@type": "MedicalCondition",
"name": "Adénocarcinome bronchioloalvéolaire",
"code": {
"@type": "MedicalCode",
"code": "D002282",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.588.894.797.520.055.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Blastome pulmonaire",
"alternateName": "Pulmonary Blastoma",
"url": "https://questionsmedicales.fr/mesh/D018202",
"about": {
"@type": "MedicalCondition",
"name": "Blastome pulmonaire",
"code": {
"@type": "MedicalCode",
"code": "D018202",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.588.894.797.520.867"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tumeurs fibreuses solitaires de la plèvre",
"alternateName": "Solitary Fibrous Tumor, Pleural",
"url": "https://questionsmedicales.fr/mesh/D054363",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs fibreuses solitaires de la plèvre",
"code": {
"@type": "MedicalCode",
"code": "D054363",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.588.894.797.640.800"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs du thorax",
"alternateName": "Thoracic Neoplasms",
"code": {
"@type": "MedicalCode",
"code": "D013899",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Yan Wang",
"url": "https://questionsmedicales.fr/author/Yan%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China."
}
},
{
"@type": "Person",
"name": "Naseema Gangat",
"url": "https://questionsmedicales.fr/author/Naseema%20Gangat",
"affiliation": {
"@type": "Organization",
"name": "Mayo Clinic, Rochester, MN, USA."
}
},
{
"@type": "Person",
"name": "Anja C Roden",
"url": "https://questionsmedicales.fr/author/Anja%20C%20Roden",
"affiliation": {
"@type": "Organization",
"name": "Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, MN."
}
},
{
"@type": "Person",
"name": "Marianne Pavel",
"url": "https://questionsmedicales.fr/author/Marianne%20Pavel",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, University Hospital Erlangen, Erlangen, Germany."
}
},
{
"@type": "Person",
"name": "Dermot O'Toole",
"url": "https://questionsmedicales.fr/author/Dermot%20O%27Toole",
"affiliation": {
"@type": "Organization",
"name": "Department of Gastroenterology, St. Vincent's University Hospital and St James's Hospital, And Trinity College Dublin, The University of Dublin, Dublin, Ireland."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A Genetic Revolution: Cancer Genetic Testing and Counseling.",
"datePublished": "2023-06-01",
"url": "https://questionsmedicales.fr/article/37195154",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": null
}
},
{
"@type": "ScholarlyArticle",
"name": "Prenatal genetic testing 1: screening tests.",
"datePublished": "2022-09-09",
"url": "https://questionsmedicales.fr/article/36081381",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MOP.0000000000001172"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prenatal genetic testing 2: diagnostic tests.",
"datePublished": "2022-09-09",
"url": "https://questionsmedicales.fr/article/36081360",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MOP.0000000000001174"
}
},
{
"@type": "ScholarlyArticle",
"name": "Elective genetic testing: Genetics professionals' perspectives and practices.",
"datePublished": "2022-12-27",
"url": "https://questionsmedicales.fr/article/36575824",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jgc4.1666"
}
},
{
"@type": "ScholarlyArticle",
"name": "Genetic Testing in Parkinson's Disease.",
"datePublished": "2023-06-27",
"url": "https://questionsmedicales.fr/article/37365908",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/mds.29500"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Tumeurs",
"item": "https://questionsmedicales.fr/mesh/D009369"
},
{
"@type": "ListItem",
"position": 3,
"name": "Tumeurs par siège",
"item": "https://questionsmedicales.fr/mesh/D009371"
},
{
"@type": "ListItem",
"position": 4,
"name": "Tumeurs du thorax",
"item": "https://questionsmedicales.fr/mesh/D013899"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Tumeurs du thorax - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Tumeurs du thorax",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-19",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Tumeurs du thorax",
"description": "Comment diagnostiquer une tumeur thoracique ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels marqueurs tumoraux sont associés aux tumeurs thoraciques ?\nQuelle est l'importance de l'histologie ?\nLes examens génétiques sont-ils utiles ?",
"url": "https://questionsmedicales.fr/mesh/D013899?mesh_terms=Genetic+Testing#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Tumeurs du thorax",
"description": "Quels sont les symptômes courants des tumeurs thoraciques ?\nLa perte de poids est-elle un symptôme ?\nLes tumeurs thoraciques causent-elles des saignements ?\nComment la fatigue se manifeste-t-elle ?\nLes symptômes varient-ils selon le type de tumeur ?",
"url": "https://questionsmedicales.fr/mesh/D013899?mesh_terms=Genetic+Testing#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Tumeurs du thorax",
"description": "Comment prévenir les tumeurs thoraciques ?\nLe dépistage est-il utile ?\nL'alimentation joue-t-elle un rôle ?\nL'exercice physique aide-t-il à prévenir ?\nLes vaccinations sont-elles importantes ?",
"url": "https://questionsmedicales.fr/mesh/D013899?mesh_terms=Genetic+Testing#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Tumeurs du thorax",
"description": "Quels traitements sont disponibles pour les tumeurs thoraciques ?\nLa chirurgie est-elle toujours nécessaire ?\nQu'est-ce que la chimiothérapie néoadjuvante ?\nLa radiothérapie est-elle efficace ?\nY a-t-il des traitements ciblés disponibles ?",
"url": "https://questionsmedicales.fr/mesh/D013899?mesh_terms=Genetic+Testing#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Tumeurs du thorax",
"description": "Quelles complications peuvent survenir ?\nLes tumeurs thoraciques peuvent-elles causer des douleurs ?\nComment les tumeurs affectent-elles la respiration ?\nLes tumeurs peuvent-elles provoquer des caillots sanguins ?\nQuelles sont les complications post-chirurgicales ?",
"url": "https://questionsmedicales.fr/mesh/D013899?mesh_terms=Genetic+Testing#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Tumeurs du thorax",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes antécédents médicaux jouent-ils un rôle ?\nL'exposition professionnelle est-elle un facteur ?\nLe mode de vie influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D013899?mesh_terms=Genetic+Testing#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une tumeur thoracique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par imagerie (radiographie, scanner) et biopsie."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent la tomodensitométrie, l'IRM et la bronchoscopie."
}
},
{
"@type": "Question",
"name": "Quels marqueurs tumoraux sont associés aux tumeurs thoraciques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les marqueurs comme le CEA et le CA 125 peuvent être utilisés pour le suivi."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'histologie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'histologie permet de déterminer le type de tumeur et son agressivité."
}
},
{
"@type": "Question",
"name": "Les examens génétiques sont-ils utiles ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils aident à identifier des mutations spécifiques pour le traitement ciblé."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des tumeurs thoraciques ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent la toux persistante, la douleur thoracique et l'essoufflement."
}
},
{
"@type": "Question",
"name": "La perte de poids est-elle un symptôme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la perte de poids inexpliquée peut être un signe de tumeur thoracique."
}
},
{
"@type": "Question",
"name": "Les tumeurs thoraciques causent-elles des saignements ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent provoquer des hémoptysies, c'est-à-dire des saignements dans les voies respiratoires."
}
},
{
"@type": "Question",
"name": "Comment la fatigue se manifeste-t-elle ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "La fatigue peut être persistante et s'aggraver avec l'évolution de la maladie."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de tumeur ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon le type et la localisation de la tumeur."
}
},
{
"@type": "Question",
"name": "Comment prévenir les tumeurs thoraciques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabagisme et l'exposition à des agents cancérigènes aide à prévenir."
}
},
{
"@type": "Question",
"name": "Le dépistage est-il utile ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage précoce peut aider à détecter les tumeurs à un stade précoce."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut réduire le risque de développer des tumeurs."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il à prévenir ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut contribuer à réduire le risque de cancer."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations, comme contre le HPV, peuvent réduire le risque de cancers associés."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les tumeurs thoraciques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chirurgie, la chimiothérapie et la radiothérapie."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle toujours nécessaire ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la chirurgie dépend du stade et de la localisation de la tumeur."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que la chimiothérapie néoadjuvante ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est un traitement administré avant la chirurgie pour réduire la taille de la tumeur."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle efficace ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est souvent utilisée pour traiter les tumeurs non opérables ou en complément."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements ciblés disponibles ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des thérapies ciblées sont disponibles pour certains types de tumeurs spécifiques."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la métastase, l'infection et l'insuffisance respiratoire."
}
},
{
"@type": "Question",
"name": "Les tumeurs thoraciques peuvent-elles causer des douleurs ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent provoquer des douleurs thoraciques dues à la pression sur les nerfs."
}
},
{
"@type": "Question",
"name": "Comment les tumeurs affectent-elles la respiration ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent obstruer les voies respiratoires, entraînant des difficultés respiratoires."
}
},
{
"@type": "Question",
"name": "Les tumeurs peuvent-elles provoquer des caillots sanguins ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent augmenter le risque de thrombose veineuse profonde."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications post-chirurgicales ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des infections, des saignements et des problèmes respiratoires."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme, l'exposition à l'amiante et les antécédents familiaux sont des facteurs clés."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de tumeurs thoraciques augmente avec l'âge."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de cancer augmentent le risque de développer des tumeurs thoraciques."
}
},
{
"@type": "Question",
"name": "L'exposition professionnelle est-elle un facteur ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines professions exposent à des substances cancérigènes, augmentant le risque."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 18/03/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Publications dans "Tumeurs du thorax" :
3 publications dans cette catégorie
Affiliations :
Mayo Clinic, Rochester, MN, USA.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, MN.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, University Hospital Erlangen, Erlangen, Germany.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Department of Gastroenterology, St. Vincent's University Hospital and St James's Hospital, And Trinity College Dublin, The University of Dublin, Dublin, Ireland.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Division of Pancreatic Surgery, Pancreas Translational & Clinical Research Center, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
University of Milan, Department of Health Sciences and S.C. Anatomia Patologica, ASST Santi Paolo e Carlo, Milan, Italy.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Institute of Pathology, University of Cologne, Cologne, Germany.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Texas Tech University Health Sciences Center, El Paso, TX, USA.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
CRIMM-Centro Ricerca e Innovazione delle Malattie Mieloproliferative, Azienda Ospedaliera-Universitaria Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Mayo Clinic, Rochester, MN, USA.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
University Clinic Wuppertal, University of Witten/Herdecke, Wuppertal, Germany. hm.kvasnicka@patho-uwh.de.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Institute of Pathology, University Medical Center Mainz, JGU-Mainz, Mainz 55131, Germany.
Joint Unit Immunopathology, Institute of Pathology, University Medical Center, JGU-Mainz and TRON, Translational Oncology at the University Medical Center, JGU-Mainz, Mainz 55131, Germany.
Institute of Pathology, Heidelberg University Hospital, Heidelberg 69120, Germany.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Department of Haematology, Queen's University, Belfast, United Kingdom.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Erzincan Binali Yildirim University, Mengucek Gazi Training and Research Hospital, Erzincan, Turkey.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Erzincan Binali Yildirim University, Mengucek Gazi Training and Research Hospital, Erzincan, Turkey.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Eskisehir City Hospital, Eskisehir, Turkey.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Erzincan Binali Yildirim University, Mengucek Gazi Training and Research Hospital, Erzincan, Turkey.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Erzincan Binali Yildirim University, Mengucek Gazi Training and Research Hospital, Erzincan, Turkey.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Erzincan Binali Yildirim University, Mengucek Gazi Training and Research Hospital, Erzincan, Turkey.
Publications dans "Tumeurs du thorax" :
Genetic counseling is a relatively young profession that has advanced rapidly over the last 50 years. The term "genetic counseling" was first coined by Sheldon Reed in 1947 to describe the advice he w...
Prenatal genetic testing can be divided into two categories: screening and diagnostic. This article will focus on reviewing prenatal genetic screening tests....
Cell-free DNA (cfDNA) is a new prenatal genetic screening test with a high degree of accuracy for identifying certain genetic conditions like trisomy 21, 18, and 13. However, cfDNA has also been appli...
Prenatal genetic screening evaluates at risk pregnancies - including both carrier screening, which can be done at any point in a person's life, and aneuploidy screening, which is done during pregnancy...
Prenatal genetic testing can be divided into two categories: screening and diagnosis. Prenatal genetic screening tests are used to assess carrier status or as a fetal risk assessment for a particular ...
Next generation sequencing (NGS) has revolutionized prenatal genetic diagnostic testing. NGS methods are becoming more advanced and accurate as more genetic information is being linked to genetic cond...
Prenatal genetic diagnostic testing involves clinicians invasively obtaining tissue via amniocentesis or chorionic villus sampling to identify if a fetus has a genetic condition. This testing has trad...
Elective genetic testing (EGT) to identify disease risk in individuals who may or may not meet clinical criteria for testing is increasingly being offered in clinical practice. However, little is know...
Genetic testing for persons with Parkinson's disease is becoming increasingly common. Significant gains have been made regarding genetic testing methods, and testing is becoming more readily available...
There are thousands of different clinical genetic tests currently available. Genetic testing and its applications continue to change rapidly for multiple reasons. These reasons include technological a...
This article considers a number of key issues and axes related to the current and future state of clinical genetic testing, including targeted versus broad testing, simple/Mendelian versus polygenic a...
Genetic testing is expanding and evolving, including into new clinical applications. Developments in the field of genetics will likely result in genetic testing becoming increasingly in the purview of...
Implementation of genetic testing in healthcare increases, but access to, and number of, genetics providers remain scarce. This study analyzed the impact of genetic counselor (GC) involvement on frequ...
To evaluate the feasibility and impact of offering genetic testing and counseling to patients with Parkinson's disease (PD), with the potential to enroll in gene-targeted clinical trials and improve c...
A multicenter, exploratory pilot study at 7 academic hospital sites in the United States tracked enrollment and randomized participants to receive results and genetic counseling at local sites or by g...
From September 5, 2019 to January 4, 2021, 620 participants were enrolled and 387 completed outcome surveys. There were no significant differences in outcomes between local and remote sites, with both...
Local clinicians, as well as genetic counselors, with educational support as needed, can effectively return genetic results for PD as we observed favorable outcome measures in both groups. Increasing ...
Clinical guidelines recommend genetic testing when evaluating congenital and late-onset sensorineural hearing loss (SNHL). Genetic diagnoses can provide parents additional information regarding antici...
We included children ages 0-18 years with SNHL who were hearing aid or cochlear implant candidates but non-users and underwent hearing-loss gene panel testing prior to initiating intervention. Univari...
Of the 385 children with SNHL who underwent hearing loss gene panel testing, 111 were included. Median age was 7.5 years. 56% were underrepresented minorities, 71% were non-White, and 71% were publicl...
Up to half of children with SNHL are suspected to have an underlying genetic etiology. Children diagnosed with a genetic diagnosis are significantly more likely to subsequently utilize hearing aids or...
4 Laryngoscope, 133:1982-1986, 2023....
Leukodystrophies are monogenic disorders primarily affecting the white matter. We aimed to evaluate the utility of genetic testing and time-to-diagnosis in a retrospective cohort of children with susp...
Medical records of patients who attended the leukodystrophy clinic at the Dana-Dwek Children's Hospital between June 2019 and December 2021 were retrieved. Clinical, molecular, and neuroimaging data w...
Sixty-seven patients (Female/Male ratio 35/32) were included. Median age at symptom onset was 9 months (interquartile range (IQR) 3-18 months), and median length of follow-up was 4.75 years (IQR 3-8.5...
NGS carries the highest diagnostic yield in children with suspected leukodystrophy. Access to advanced sequencing technologies accelerates speed to diagnosis, which is increasingly crucial as targeted...